Top compounds associated with response to LRRC9


Feature Type Standardized
Nominal ANOVA
mRNA LE-135 CTRPv2 pan-cancer AAC 0.029 0.4
mRNA WZ4002 CTRPv2 pan-cancer AAC 0.036 0.4
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.027 0.4
mRNA ZSTK474 CTRPv2 pan-cancer AAC -0.03 0.4
mRNA GSK1059615 CTRPv2 pan-cancer AAC 0.036 0.4
mRNA neratinib CTRPv2 pan-cancer AAC -0.028 0.4
mRNA MK 1775 CTRPv2 pan-cancer AAC 0.027 0.4
mRNA FGIN-1-27 CTRPv2 pan-cancer AAC -0.057 0.4
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.026 0.4
mRNA CHEMBL374350 CTRPv2 pan-cancer AAC -0.029 0.4
Download CSV